We support calls for funding into research using stem cells to continue

15 June 2012

The European Parliament is currently debating how much money it should invest in its research plans for the future.

Part of these plans look at how much money they should give to research involving stem cells, and in particular embryonic stem cells. This could affect research that is undertaken into Parkinson's.

Tremendous potential

Stem cells are special cells that are capable of becoming any of the 200 different types of cells that make up the human body. This is how the body refreshes itself and replaces cells as needed such as skin and some internal organs.

This means that stem cells could be particularly promising for Parkinson's research to help us to better understand the condition.

And if they were transformed into the dopamine-producing nerve cells that die in Parkinson's, we may be able to transplant them in to replace the dead cells.

Although many different types of stem cells are being investigated to treat Parkinson's, embryonic stem cells currently appear to have the most potential to work.

However, research is being carried out to determine whether other more accessible sources of stem cells may be used. This means it is critical that investment in stem cells continues.

Vital avenue of research

Dr Kieran Breen, our Director of Research and Innovation, explains:

"Stem cells have great potential for the treatment of Parkinson's in the future. It is vital that we keep this avenue of research open to ensure that all areas of stem cell research are explored.

"By raising a barrier to future research in this area, we will slow down the development of stem cell technology and this could prevent the development of better treatments for people with Parkinson's which would bring us closer to our ultimate goal of a cure for the condition."

• email
• Share